Godsfavour Umoru

10PUBLICATIONS
16CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 08, 2026
Treatment Outcomes of Advanced Stage Classical Hodgkin Lymphoma in the Setting of Vinblastine and Dacarbazine Shortages: A Case Series.

Ishwarya Satyavarapu, Noah Giese, Prakruti Gandhi

|Dec 05, 2024
Effect of direct oral anticoagulants compared to enoxaparin on objective response to immune checkpoint inhibitors in patients with lung cancer.

Solmaz Karimi, Karen Abboud, Godsfavour Umoru

|Jul 23, 2024
Immune checkpoint blockade effect on immunologic and virologic profile of five cancer patients living with human immunodeficiency virus (HIV) infection.

Azzam Yazji, Erika Nicole Brown, Rodrigo De La Torre

|Apr 05, 2024
Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation.

Clement Chung, Godsfavour Umoru

|Apr 10, 2023
Sequencing and combination of current small-molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence?

Clement Chung, Godsfavour Umoru, Karen Abboud

Pageof 2